| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-07 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-07 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |